Your browser doesn't support javascript.
loading
Switching to fingolimod in PREFERMS: Effect of treatment history and naïvety on clinical, MRI and treatment satisfaction outcomes✰.
Hunter, Samuel F; Thomas, Florian P; Cascione, Mark; Williams, Ian M; Meng, Xiangyi; Schofield, Lesley; Weiss, Jamie L; Tenenbaum, Nadia; Cree, Bruce A C.
Afiliación
  • Hunter SF; Advanced Neurosciences Institute, 101 Forrest Crossing Blvd. Suite 103, Franklin, TN 37064, United States. Electronic address: sfhunter@neurosci.us.
  • Thomas FP; Hackensack Meridian School of Medicine at Seton Hall University, South Orange, and Hackensack University Medical Center, Hackensack, NJ, United States. Electronic address: florian.thomas@hackensackmeridian.org.
  • Cascione M; Tampa Neurology Associates, Tampa, FL, United States. Electronic address: me@markcascione.com.
  • Williams IM; Oxford PharmaGenesis, Oxford, United Kingdom. Electronic address: ian.williams@pharmagenesis.com.
  • Meng X; Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States. Electronic address: xiangyi.meng@novartis.com.
  • Schofield L; Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States. Electronic address: lesley.schofield@novartis.com.
  • Weiss JL; Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States. Electronic address: jamie.weiss@novartis.com.
  • Tenenbaum N; Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States. Electronic address: nadia.tenebaum@novartis.com.
  • Cree BAC; UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, United States. Electronic address: bruce.cree@ucsf.edu.
Mult Scler Relat Disord ; 45: 102346, 2020 Oct.
Article en En | MEDLINE | ID: mdl-32717684

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Clorhidrato de Fingolimod Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2020 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Clorhidrato de Fingolimod Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2020 Tipo del documento: Article Pais de publicación: Países Bajos